In this compelling personal account, a patient describes her year-long journey battling what ultimately was identified as subacute invasive aspergillosis. She walks us through months of worsening symptoms, repeated rounds of antifungals, diagnostic uncertainty, and the pivotal decision to undergo lung surgery. The turning point: removal of a single lesion led to a rapid resolution of systemic infection signs, with follow-up therapy and monitoring guided by her infectious disease team. Her story highlights how, with very little precedent in medical literature, patients and clinicians sometimes must walk together on uncharted ground.
👉 Read the full article here:
“Aspergillus Saga – July 2024 to June 2025: Searching for the Invisible” Beauty for Ashes
Share this post
Latest News posts
How the Body Handles Chemicals, Medicines, and Antifungals
January 27, 2026
Airways mucus and aspergillosis
January 27, 2026
Latest Aspergillosis & Related Research Updates (Week 3).
January 26, 2026
When discharge from a specialist service is being discussed
January 20, 2026
Hyper-IgE syndrome
January 20, 2026
January–February 2026 Aspergillosis Papers (week 3)
January 19, 2026
What’s New in Aspergillosis Clinical Trials (Last ~4 Months)
January 19, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
